Related Experiment Video
Updated: Aug 13, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Diminished hepatic L-triiodothyronine nuclear receptor concentration in rats bearing the Walker 256 carcinoma is not
Z Starosta1, F Gasparini, L E Shapiro
1Department of Medicine, Montefiore Medical Center, Bronx, New York 10467.
Abstract:
To determine whether the decrease in hepatic T3 nuclear receptors in rats bearing the Walker 256 carcinoma (T rats) is a consequence of nonthyroidal disease or related to a generalized decrease in hepatic protein synthesis, we measured hepatic T3 nuclear receptors and [3H]leucine incorporation into protein in control and T rats. Mean protein contents of liver homogenate, purified nuclei, 0.4 M NaCl extracts of nuclei, and nonhistone protein fractions were similar in control and T rats. In pooled data from three experiments, [3H]leucine incorporation into protein in these liver fractions was significantly increased (55-73%) in T rats. Since the precursor nonradioactive leucine pool, measured by a novel HPLC method, was similar in control and T rats, the increased incorporation of [3H]leucine in all liver fractions suggests an increase in protein synthesis in T rats. Additional measurements in the same rats (two experiments) indicated that hepatic nuclear receptors were decreased to 50% of the control value in T rats (P less than 0.001). Our findings suggest that in the Walker tumor model of nonthyroidal disease, decreased hepatic nuclear T3 receptors appears relatively specific and is not associated with a generalized decrease in hepatic protein synthesis.
More Related Videos
04:14In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
Published on: October 6, 2023
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase